Investigation of the role of TCF4 rare sequence variants in schizophrenia

American Journal of Medical Genetics, Part B: Neuropsychiatric Genetics

Volumn 168, Issue 5, 2015, Pages 354-362

  Basmanav, F Buket ^a,b   Forstner, Andreas J ^a,b   Fier, Heide ^a,b   Herms, Stefan ^b,c   Meier, Sandra ^d,e   Degenhardt, Franziska ^a,b   Hoffmann, Per ^a,b,c,f   Barth, Sandra ^a,b   Fricker, Nadine ^a,b   Strohmaier, Jana ^d   Witt, Stephanie H ^d   Ludwig, Michael ^a   Schmael, Christine ^a,d   Moebus, Susanne ^g   Maier, Wolfgang ^a   Mössner, Rainald ^a,h   Rujescu, Dan ⁱ   Rietschel, Marcella ^d   Lange, Christoph ^a,j,k   Nöthen, Markus M ^a,b   Cichon, Sven ^a,b,c,f   more..

^a UNIVERSITY OF BONN   (Germany)

^b Life and Brain Center   (Germany)

^c UNIVERSITY HOSPITAL BASEL   (Switzerland)

^d MEDICAL FACULTY MANNHEIM HEIDELBERG UNIVERSITY   (Germany)

^e AARHUS UNIVERSITY   (Denmark)

^f FORSCHUNGSZENTRUM JÜLICH   (Germany)

^g UNIVERSITY HOSPITAL ESSEN   (Germany)

^h UNIVERSITY OF TÜBINGEN   (Germany)

ⁱ MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

^j GERMAN CENTER FOR NEURODEGENERATIVE DISEASES DZNE   (Germany)

^k HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

more..

Author keywords

Neurodevelopmental disorder; Rare variants; Resequencing; Schizophrenia; Transcription factor 4

Indexed keywords

ADULT; ARTICLE; CASE CONTROL STUDY; COHORT ANALYSIS; CONTROLLED STUDY; EXON; FEMALE; GENE; GENE SEQUENCE; GENETIC ASSOCIATION; GENETIC RISK; GENETIC VARIABILITY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; MISSENSE VARIANT; PRIORITY JOURNAL; SCHIZOPHRENIA; SINGLE NUCLEOTIDE POLYMORPHISM; SINGLE NUCLEOTIDE VARIANT; SPLICE SITE VARIANT; TCF4 GENE; CAUCASIAN; GENETIC PREDISPOSITION; GENETIC VARIATION; GENETICS;

BASIC HELIX LOOP HELIX LEUCINE ZIPPER TRANSCRIPTION FACTOR; TCF4 PROTEIN, HUMAN; TRANSCRIPTION FACTOR;

BASIC HELIX-LOOP-HELIX LEUCINE ZIPPER TRANSCRIPTION FACTORS; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENETIC VARIATION; GENOTYPE; HUMANS; MALE; SCHIZOPHRENIA; TRANSCRIPTION FACTORS;

EID: 84930930603     PISSN: 15524841     EISSN: 1552485X     Source Type: Journal    
DOI: 10.1002/ajmg.b.32318     Document Type: Article

References (55)

1. Abecasis GR, Auton A, Brooks LD, DePristo MA, Durbin RM, Handsaker RE, Kang HM, Marth GT, McVean GA. 2012. An integrated map of genetic variation from 1, 092 human genomes. Nature 491:56-65.
2. Aleksic B, Kushima I, Hashimoto R, Ohi K, Ikeda M, Yoshimi A, Nakamura Y, Ito Y, Okochi T, Fukuo Y, et al. 2012. Analysis of the VAV3 as candidate gene for schizophrenia: Evidences from voxel-based morphometry and mutation screening. Schizophr Bull 39:720-728.
3. Basu S, Pan W. 2011. Comparison of statistical tests for disease association with rare variants. Genet Epidemiol 35:606-619.
4. Blake DJ, Forrest M, Chapman RM, Tinsley CL, O'Donovan MC, Owen MJ. 2010. TCF4, schizophrenia, and Pitt-Hopkins Syndrome. Schizophr Bull 36:443-447.
5. Bonnefond A, Clement N, Fawcett K, Yengo L, Vaillant E, Guillaume JL, Dechaume A, Payne F, Roussel R, Czernichow S, et al. 2012. Rare MTNR1B variants impairing melatonin receptor 1B function contribute to type 2 diabetes. Nat Genet 44:297-301.
6. Brzozka MM, Radyushkin K, Wichert SP, Ehrenreich H, Rossner MJ. 2010. Cognitive and sensorimotor gating impairments in transgenic mice overexpressing the schizophrenia susceptibility gene Tcf4 in the brain. Biol Psychiatry 68:33-40.
7. Diogo D, Kurreeman F, Stahl EA, Liao KP, Gupta N, Greenberg JD, Rivas MA, Hickey B, Flannick J, Thomson B, et al. 2013. Rare, low-frequency, and common variants in the protein-coding sequence of biological candidate genes from GWASs contribute to risk of Rheumatoid arthritis. Am J Hum Genet 92:15-27.
8. Dow DJ, Huxley-Jones J, Hall JM, Francks C, Maycox PR, Kew JN, Gloger IS, Mehta NA, Kelly FM, Muglia P, et al. 2011. ADAMTSL3 as a candidate gene for schizophrenia: Gene sequencing and ultra-high density association analysis by imputation. Schizophr Res 127:28-34.
9. Dwyer S, Williams H, Holmans P, Moskvina V, Craddock N, Owen MJ, O'Donovan MC. 2010. No evidence that rare coding variants in ZNF804A confer risk of schizophrenia. Am J Med Genet B Neuropsychiatr Genet Part B 153B:1411-1416.
10. Flora A, Garcia JJ, Thaller C, Zoghbi HY. 2007. The E-protein Tcf4 interacts with Math1 to regulate differentiation of a specific subset of neuronal progenitors. Proc Natl Acad Sci USA 104:15382-15387.
11. Forrest M, Chapman RM, Doyle AM, Tinsley CL, Waite A, Blake DJ. 2012. Functional analysis of TCF4 missense mutations that cause Pitt-Hopkins syndrome. Hum Mutat 33:1676-1686.
12. Frank RA, McRae AF, Pocklington AJ, van de Lagemaat LN, Navarro P, Croning MD, Komiyama NH, Bradley SJ, Challiss RA, Armstrong JD, et al. 2011. Clustered coding variants in the glutamate receptor complexes of individuals with schizophrenia and bipolar disorder. PLoS ONE 6: e19011.
13. Friedrich FW, Dilanian G, Khattar P, Juhr D, Gueneau L, Charron P, Fressart V, Vilquin JT, Isnard R, Gouya L, et al. 2013. A novel genetic variant in the transcription factor Islet-1 exerts gain of function on myocyte enhancer factor 2C promoter activity. Eur J Heart Fail 15:267-276.
14. Fu H, Cai J, Clevers H, Fast E, Gray S, Greenberg R, Jain MK, Ma Q, Qiu M, Rowitch DH, et al. 2009. A genome-wide screen for spatially restricted expression patterns identifies transcription factors that regulate glial development. J Neurosci 29:11399-11408.
15. Girard SL, Gauthier J, Noreau A, Xiong L, Zhou S, Jouan L, Dionne-Laporte A, Spiegelman D, Henrion E, Diallo O, et al. 2011. Increased exonic de novo mutation rate in individuals with schizophrenia. Nat Genet 43:860-863.
16. Gratten J, Wray NR, Keller MC, Visscher PM. 2014. Large-scale genomics unveils the genetic architecture of psychiatric disorders. Nat Neurosci 17:782-790.
17. Gravel S, Henn BM, Gutenkunst RN, Indap AR, Marth GT, Clark AG, Yu F, Gibbs RA, Bustamante CD. 2011. Demographic history and rare allele sharing among human populations. Proc Natl Acad Sci USA 108:11983-11988.
18. Hu X, Zhang B, Liu W, Paciga S, He W, Lanz TA, Kleiman R, Dougherty B, Hall SK, McIntosh AM, et al. 2013. A survey of rare coding variants in candidate genes in schizophrenia by deep sequencing. Mol Psychiatry DOI: 10.1038/mp.2013.131. [Epub ahead of print]
19. Ionita-Laza I, Buxbaum JD, Laird NM, Lange C. 2011. A new testing strategy to identify rare variants with either risk or protective effect on disease. PLoS Genet 7:e1001289.
20. Johansen CT, Wang J, Lanktree MB, Cao H, McIntyre AD, Ban MR, Martins RA, Kennedy BA, Hassell RG, Visser ME, et al. 2010. Excess of rare variants in genes identified by genome-wide association study of hypertriglyceridemia. Nat Genet 42:684-687.
21. Kiezun A, Garimella K, Do R, Stitziel NO, Neale BM, McLaren PJ, Gupta N, Sklar P, Sullivan PF, Moran JL, et al. 2012. Exome sequencing and the genetic basis of complex traits. Nat Genet 44:623-630.
22. Kushima I, Nakamura Y, Aleksic B, Ikeda M, Ito Y, Shiino T, Okochi T, Fukuo Y, Ujike H, Suzuki M, et al. 2012. Resequencing and association analysis of the KALRN and EPHB1 genes and their contribution to schizophrenia susceptibility. Schizophr Bull 38:552-560.
23. Li B, Leal SM. 2008. Methods for detecting associations with rare variants for common diseases: Application to analysis of sequence data. Am J Hum Genet 83:311-321.
24. Li B, Leal SM. 2009. Discovery of rare variants via sequencing: Implications for the design of complex trait association studies. PLoS Genet 5:e1000481.
25. Madsen BE, Browning SR. 2009. A groupwise association test for rare mutations using a weighted sum statistic. PLoS Genet 5:e1000384.
26. Mathieson I, McVean G. 2012. Differential confounding of rare and common variants in spatially structured populations. Nat Genet 44:243-246.
27. Moens LN, De Rijk P, Reumers J, Van den Bossche MJ, Glassee W, De Zutter S, Lenaerts AS, Nordin A, Nilsson LG, Medina Castello I, et al. 2011. Sequencing of DISC1 pathway genes reveals increased burden of rare missense variants in schizophrenia patients from a northern Swedish population. PLoS ONE 6:e23450.
28. Mowry BJ, Gratten J. 2012. The emerging spectrum of allelic variation in schizophrenia: Current evidence and strategies for the identification and functional characterization of common and rare variants. Mol Psychiatry 18:38-52.
29. Navarrete K, Pedroso I, De Jong S, Stefansson H, Steinberg S, Stefansson K, Ophoff RA, Schalkwyk LC, Collier DA. 2013. TCF4 (e2-2; ITF2): A schizophrenia-associated gene with pleiotropic effects on human disease. Am J Med Genet B 162B:1-16.
30. Neale BM, Rivas MA, Voight BF, Altshuler D, Devlin B, Orho-Melander M, Kathiresan S, Purcell SM, Roeder K, Daly MJ. 2011. Testing for an unusual distribution of rare variants. PLoS Genet 7:e1001322.
31. Need AC, McEvoy JP, Gennarelli M, Heinzen EL, Ge D, Maia JM, Shianna KV, He M, Cirulli ET, Gumbs CE, et al. 2012. Exome sequencing followed by large-scale genotyping suggests a limited role for moderately rare risk factors of strong effect in schizophrenia. Am J Hum Genet 91:303-312.
32. Nelson MR, Wegmann D, Ehm MG, Kessner D, St Jean P, Verzilli C, Shen J, Tang Z, Bacanu SA, Fraser D, et al. 2012. An abundance of rare functional variants in 202 drug target genes sequenced in 14, 002 people. Science 337:100-104.
33. Perrotta S, Stiehl DP, Punzo F, Scianguetta S, Borriello A, Bencivenga D, Casale M, Nobili B, Fasoli S, Balduzzi A, et al. 2013. Congenital erythrocytosis associated with gain-of-function HIF2A gene mutations and erythropoietin levels in the normal range. Haematologica 98:1624-1632.
34. Persson P, Jogi A, Grynfeld A, Pahlman S, Axelson H. 2000. HASH-1 and E2-2 are expressed in human neuroblastoma cells and form a functional complex. Biochem Biophys Res Commun 274:22-31.
35. Piton A, Gauthier J, Hamdan FF, Lafreniere RG, Yang Y, Henrion E, Laurent S, Noreau A, Thibodeau P, Karemera L, et al. 2011. Systematic resequencing of X-chromosome synaptic genes in autism spectrum disorder and schizophrenia. Mol Psychiatry 16:867-880.
36. Price AL, Kryukov GV, de Bakker PI, Purcell SM, Staples J, Wei LJ, Sunyaev SR. 2010. Pooled association tests for rare variants in exon-resequencing studies. Am J Hum Genet 86:832-838.
37. Purcell SM, Moran JL, Fromer M, Ruderfer D, Solovieff N, Roussos P, O'Dushlaine C, Chambert K, Bergen SE, Kähler A, et al. 2014. A polygenic burden of rare disruptive mutations in schizophrenia. Nature 506:185-190.
38. Ravanpay AC, Olson JM. 2008. E protein dosage influences brain development more than family member identity. J Neurosci Res 86:1472-1481.
39. Ripke S, Sanders AR, Kendler KS, Levinson DF, Sklar P, Holmans PA, Lin DY, Duan J, Ophoff RA, Andreassen OA, et al. 2011. Genome-wide association study identifies five new schizophrenia loci. Nat Genet 43:969-976.
40. Rivas MA, Beaudoin M, Gardet A, Stevens C, Sharma Y, Zhang CK, Boucher G, Ripke S, Ellinghaus D, Burtt N, et al. 2011. Deep resequencing of GWAS loci identifies independent rare variants associated with inflammatory bowel disease. Nat Genet 43:1066-1073.
41. Schizophrenia Working Group of the Psychiatric Genomics Consortium. 2014. Biological insights from 108 schizophrenia-associated genetic loci. Nature 511:421-427.
42. Schmermund A, Mohlenkamp S, Stang A, Gronemeyer D, Seibel R, Hirche H, Mann K, Siffert W, Lauterbach K, Siegrist J, et al. 2002. Assessment of clinically silent atherosclerotic disease and established and novel risk factors for predicting myocardial infarction and cardiac death in healthy middle-aged subjects: Rationale and design of the Heinz Nixdorf RECALL Study. Risk Factors, Evaluation of Coronary Calcium and Lifestyle. Am Heart J 144:212-218.
43. Sepp M, Kannike K, Eesmaa A, Urb M, Timmusk T. 2011. Functional diversity of human basic helix-loop-helix transcription factor TCF4 isoforms generated by alternative 5' exon usage and splicing. PLoS ONE 6:e22138.
44. Sepp M, Pruunsild P, Timmusk T. 2012. Pitt-Hopkins syndrome-associated mutations in TCF4 lead to variable impairment of the transcription factor function ranging from hypomorphic to dominant-negative effects. Hum Mol Genet 21:2873-2888.
45. Shen YC, Liao DL, Lu CL, Chen JY, Liou YJ, Chen TT, Chen CH. 2010. Resequencing of the vesicular glutamate transporter 2 gene (VGLUT2) reveals some rare genetic variants that may increase the genetic burden in schizophrenia. Schizophr Res 121:179-186.
46. Shen YC, Tsai HM, Cheng MC, Hsu SH, Chen SF, Chen CH. 2012. Genetic and functional analysis of the gene encoding neurogranin in schizophrenia. Schizophr Res 137:7-13.
47. Song W, Li W, Feng J, Heston LL, Scaringe WA, Sommer SS. 2008. Identification of high risk DISC1 structural variants with a 2% attributable risk for schizophrenia. Biochem Biophys Res Commun 367:700-706.
48. Stefansson H, Ophoff RA, Steinberg S, Andreassen OA, Cichon S, Rujescu D, Werge T, Pietilainen OP, Mors O, Mortensen PB, et al. 2009. Common variants conferring risk of schizophrenia. Nature 460:744-747.
49. Steinberg S, de Jong S, Andreassen OA, Werge T, Borglum AD, Mors O, Mortensen PB, Gustafsson O, Costas J, Pietilainen OP, et al. 2011. Common variants at VRK2 and TCF4 conferring risk of schizophrenia. Hum Mol Genet 20:4076-4081.
50. Sullivan PF, Daly MJ, O'Donovan M. 2012. Genetic architectures of psychiatric disorders: the emerging picture and its implications. Nat Rev Genet 13:537-551.
51. Treutlein J, Cichon S, Ridinger M, Wodarz N, Soyka M, Zill P, Maier W, Moessner R, Gaebel W, Dahmen N, et al. 2009. Genome-wide association study of alcohol dependence. Arch Gen Psychiatry 66:773-784.
52. Wirgenes KV, Sonderby IE, Haukvik UK, Mattingsdal M, Tesli M, Athanasiu L, Sundet K, Rossberg JI, Dale AM, Brown AA, et al. 2012. TCF4 sequence variants and mRNA levels are associated with neurodevelopmental characteristics in psychotic disorders. Trans Psychiatry 2:e112.
53. Wu MC, Lee S, Cai T, Li Y, Boehnke M, Lin X. 2011. Rare-variant association testing for sequencing data with the sequence kernel association test. Am J Hum Genet 89:82-93.
54. Xu B, Roos JL, Dexheimer P, Boone B, Plummer B, Levy S, Gogos JA, Karayiorgou M. 2011. Exome sequencing supports a de novo mutational paradigm for schizophrenia. Nat Genet 43:864-868.
55. Yagnik G, Ghuman A, Kim S, Stevens CG, Kimonis V, Stoler J, Sanchez-Lara PA, Bernstein JA, Naydenov C, Drissi H, et al. 2012. ALX4 gain-of-function mutations in nonsyndromic craniosynostosis. Hum Mutat 33:1626-1629.